281 results on '"Schampaert, Erick"'
Search Results
2. Primary Percutaneous Coronary Intervention and Application of the Pharmacoinvasive Approach Within ST-Elevation Myocardial Infarction Care Networks
3. Double-blind, placebo-controlled evaluation of biorest liposomal alendronate in diabetic patients undergoing PCI: The BLADE-PCI trial
4. Immediate vs Delayed Stenting in ST-Elevation Myocardial Infarction: Rationale and Design of the International PRIMACY Bayesian Randomized Controlled Trial
5. Incidence and Prognostic Impact of Atrial Fibrillation After Discharge Following Revascularization for Significant Left Main Coronary Artery Narrowing
6. Algorithmic Versus Expert Human Interpretation of Instantaneous Wave-Free Ratio Coronary Pressure-Wire Pull Back Data
7. Bypass Surgery or Stenting for Left Main Coronary Artery Disease in Patients With Diabetes
8. Long-Term Survival Following Multivessel Revascularization in Patients With Diabetes: The FREEDOM Follow-On Study
9. 2019 Canadian Cardiovascular Society/Canadian Association of Interventional Cardiology Guidelines on the Acute Management of ST-Elevation Myocardial Infarction: Focused Update on Regionalization and Reperfusion
10. Inaccuracy of brachial blood pressure and its potential impact on treatment and aortic blood pressure estimation
11. New-Onset Atrial Fibrillation After PCI or CABG for Left Main Disease: The EXCEL Trial
12. Longitudinal treatment patterns with ADP receptor inhibitors after myocardial infarction: Insights from the Canadian Observational AntiPlatelet sTudy
13. Nonculprit Lesion Plaque Morphology in Patients With ST-Segment–Elevation Myocardial Infarction: Results From the COMPLETE Trial Optical Coherence Tomography Substudys
14. Brain Natriuretic Peptide Levels and the Occurrence of Subclinical Pulmonary Edema in Healthy Lowlanders at High Altitude
15. THE ASSOCIATIONS OF EDUCATION AND INCOME WITH THE RISK OF ATHEROSCLEROTIC CARDIOVASCULAR DISEASE WITHIN A UNIVERSAL HEALTHCARE SYSTEM: INSIGHTS FROM THE CARTAGENE STUDY
16. Genetic determinants of response to aspirin: Appraisal of 4 candidate genes
17. Heterogeneity in platelet cyclooxygenase inhibition by aspirin in coronary artery disease
18. Safety and effectiveness of enoxaparin following fibrinolytic therapy: Results of the Acute Myocardial Infarction (AMI)-QUEBEC registry
19. Platelet count, not oxidative stress, may contribute to inadequate platelet inhibition by aspirin
20. Impact of Moderate Renal Insufficiency on Restenosis and Adverse Clinical Events After Sirolimus-Eluting and Bare Metal Stent Implantation (from the SIRIUS Trials)
21. Insights into the interpretation of light transmission aggregometry for evaluation of platelet aggregation inhibition by clopidogrel
22. Evaluation of the platelet count drop method for assessment of platelet function in comparison with “gold standard” light transmission aggregometry
23. Prevalence of Unresponsiveness to Aspirin and/or Clopidogrel in Patients With Stable Coronary Heart Disease
24. Racial disparities in acute coronary syndrome management within a universal healthcare context: Insights from the AMI-OPTIMA trial
25. RACIAL DISPARITIES IN ACUTE CORONARY SYNDROME MANAGEMENT WITHIN THE CANADIAN UNIVERSAL HEALTHCARE SYSTEM: INSIGHTS FROM THE AMI-OPTIMA TRIAL
26. CUFF-BASED AND INTRAARTERIAL BRACHIAL BLOOD PRESSURE MISMATCH AND ITS POTENTIAL IMPACT ON ANTIHYPERTENSIVE TREATMENT AND ESTIMATION OF AORTIC BLOOD PRESSURE
27. Gender-Specific Outcomes After Sirolimus-Eluting Stent Implantation
28. Cost Effectiveness of the Sirolimus-Eluting Stent in High-Risk Patients in Canada: An Analysis from the C-SIRIUS Trial
29. Safety and efficacy of sirolimus- and paclitaxel-eluting coronary stents
30. Immediate vs Delayed Stenting in ST-Elevation Myocardial Infarction:Rationale and Design of the International PRIMACY Bayesian Randomized Controlled Trial
31. The Canadian Association of Interventional Cardiology and the Canadian Cardiovascular Society joint statement on drug-eluting stents
32. Progressive epicardial coronary blood flow reduction fails to produce ST-segment depression at normal heart rates
33. Porcine model of intracoronary pulverization of stent struts by rotablation atherectomy
34. Canada Acute Coronary Syndrome Risk Score: A new risk score for early prognostication in acute coronary syndromes
35. Periprocedural and Late Consequences of Overlapping Cypher Sirolimus-Eluting Stents: Pooled Analysis of Five Clinical Trials
36. TCT CONNECT-299 Long-Term Clinical Outcomes After Revascularization With PCI and CABG for Left Main Disease in Elderly Versus Young Patients: The EXCEL trial
37. Immediate Versus Delayed Stenting in Patients with Acute ST-Elevation Myocardial Infarction: A Randomized Open-Label Bayesian Trial
38. Week-Long High-Maintenance Dose Clopidogrel Regimen Achieves Better Platelet Aggregation Inhibition than a Standard Loading Dose before Percutaneous Coronary Intervention: Results of a Double-Blind, Randomized Clinical Trial
39. Comparison of four tests to assess inhibition of platelet function by clopidogrel in stable coronary artery disease patients
40. Assessment of VerifyNow P2Y12 Assay Accuracy in Evaluating Clopidogrel-Induced Platelet Inhibition
41. Impact of Platelet Glycoprotein Iib/Iiia Receptor Inhibitors on Outcomes of Diabetic Patients Undergoing Percutaneous Coronary Interventions Using Sirolimus-Eluting Stents
42. Five-Year Outcomes after PCI or CABG for Left Main Coronary Disease
43. A comparison of six major platelet function tests to determine the prevalence of aspirin resistance in patients with stable coronary artery disease
44. Drug-eluting stents
45. Delays to reperfusion therapy in acute ST-segment elevation myocardial infarction: results from the AMI-QUEBEC Study
46. Cause of death with bare metal and sirolimus-eluting stents†
47. The Canadian study of the sirolimus-eluting stent in the treatment of patients with long de novo lesions in small native coronary arteries (C-SIRIUS)
48. Sirolimus-eluting stents for treatment of patients with long atherosclerotic lesions in small coronary arteries: double-blind, randomised controlled trial (E-SIRIUS)
49. Five-Year Outcomes after PCI or CABG for Left Main Coronary Disease
50. TCT-306 Association Between Prediabetes and Clinical Outcomes After Left Main Coronary Artery Revascularization by PCI or CABG: Analysis From the EXCEL Trial
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.